Exclusive

Publication

Byline

Singapore Clinical Trial: A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination with Osimertinib as First-Line Treatment in Patients with Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Singapore, April 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab A... Read More


Singapore Clinical Trial: A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Retained Gastric Contents Using Gastric Ultrasound in Participants with Type 2 Diabetes Mellitus and Participants with Overweight or Obesity without Type 2 Diabetes Mellitus.

Singapore, April 7 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Ret... Read More


Singapore Clinical Trial: A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06E

Singapore, April 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination Wi... Read More


Singapore Clinical Trial: EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, hypertension and established cardiovascular disease

Singapore, April 7 -- The Health Sciences Authority received information related to the study titled 'EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate ... Read More


Singapore unveils support package amid 'unprecedented' global energy crisis

SINGAPORE, April 7 -- The Singapore government has announced a relief package to help shield households and businesses from the fallout of the Middle East conflict, which has triggered what officials ... Read More


Tata Mutual Fund has announced the resumption of subscriptions in its Tata Small Cap Fund

Mumbai, April 7 -- Tata Mutual Fund has announced the resumption of subscriptions in its Tata Small Cap Fund effective April 06, 2026, allowing investors to invest through lumpsum and switch-ins. Pub... Read More


Honda Cars India announces discounts of up to Rs.1.97 lakh for April 2026

India, April 7 -- Honda Cars India has rolled out discounts across its entire lineup for April 2026, with benefits available on all models currently on sale. The offers cover the 3rd-generation Honda ... Read More


'Just to share blessings': Sponsor defends crying competition in Kelantan after backlash

KOTA BHARU, April 7 -- A sponsor of a crying competition in Kelantan has defended the event after it drew criticism online, saying participants joined voluntarily and the aim was simply to "share bles... Read More


Dhurandhar 2 Collection: 1622 కోట్లు కొల్లగొట్టిన ధురంధర్ 2- ఇండియాలో 1023 కోట్లు- వారాల వారీగా వసూల్లు ఇలా!

భారతదేశం, ఏప్రిల్ 7 -- బాలీవుడ్ స్టార్ హీరో రణ్‌వీర్ సింగ్ ప్రధాన పాత్రలో దర్శకుడు ఆదిత్య ధర్ రూపొందించిన 'ధురంధర్ 2: ది రివెంజ్' బాక్సాఫీస్ వద్ద తన జైత్రయాత్రను నిరాటంకంగా కొనసాగిస్తోంది. భారతదేశంలో ... Read More


Power crisis hits hard: Pakistan orders early shutdown of markets nationwide, barring Sindh

India, April 7 -- The Pakistan government has decided to close markets and shopping malls across the country by 8 pm-except in Sindh-as part of energy conservation measures amid the ongoing Middle Eas... Read More